Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Selective 5-HT1D receptor agonist active in two migraine models

July 4, 1997

FDA approves Mirapex for the treatment of Parkinson's disease

July 3, 1997

CoCensys reports on phase II trial with ganaxolone

July 2, 1997

Full 5-HT1A receptor antagonist described by Duphar

July 2, 1997

Human PEP inhibitor isolated from microbial sources

July 2, 1997

Potent and selective dopamine D3 ligands from ADIR

July 2, 1997

Algene and Janssen extend collaboration in genetic study of schizophrenia

July 1, 1997

Neuroprotective effects of NMDA antagonists in animal models

July 1, 1997

MS-322: new centrally acting muscle relaxant with little CNS depressant activity

July 1, 1997

Lidocaine/prilocaine cream effective and safe in neonatal circumcision

July 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...